Company
Phil
PHIL is the digital hub and direct-to-patient platform that helps pharma brands maximize starts, coverage, adherence, and commercial performance.
Also known as Phil, Inc.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B2C
- Headquarters
- Scottsdale, AZ, United States
- Customers
- pharma brands
- Legal name
- Phil, Inc.
- phil.us (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
We help retail and specialty-lite brands break through access barriers to improve commercial performance. Our end-to-end digital hub and direct-to-patient platform delivers strong results through human-first care, innovative technology, and AI-supported outcomes.
Funding snapshot
- Total raised
- $7MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $5.5M2016-11-21
Funding rounds
- Round, 2016
- $5.5M2016-11-21, SEC form D sold, 13 investors
- Round, 2015
- $1.5M2015-08-07, SEC form D sold, 3 investors
Products
- Web
- PHILRx
Loading relationship preview